X0508 4 2024-10-23 0001662774 Quince Therapeutics, Inc. QNCX 0001613842 Benatti Luca C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BOULEVARD, SUITE 273 SOUTH SAN FRANCISCO CA 94080 true false false false false Common Stock 2024-10-23 4 J false 8918 A 89179 D In connection with the Stock Purchase Agreement between the Issuer and EryDel Italy Inc.announced in the Issuer's 8-k filed with the Securities and Exchange Commission on July 24, 2023 (the "Acquisition"), 10% of the shares of common stock of the Issuer issued to the Reporting Person in connection with the Acquisition were held back for one (1) year following closing and released to the Reporting Person on October 23, 2024. /s/ Brendan Hannah as attorney-in-fact for Luca Benatti 2025-12-29